US Biomax, Inc.

BC01071a

Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing BC01071

Microarray Panel:Multiple organ carcinoma tissue microarray, containing 12 cases of stomach adenocarcinoma, 4 adjacent normal stomach tissue, 12 liver hepatocellular carcinoma, 4 adjacent normal liver tissue, 12 rectum adenocarcinoma, 4 adjacent normal rectum tissue, single core per case
Cores:48
Cases:48
Layout:8 cols × 6 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678 
A Sto Sto Sto Sto Sto Sto Sto Sto  
B Sto Sto Sto Sto Sto Sto Sto Sto  
C Liv Liv Liv Liv Liv Liv Liv Liv  
D Liv Liv Liv Liv Liv Liv Liv Liv  
E Rec Rec Rec Rec Rec Rec Rec Rec  
F Rec Rec Rec Rec Rec Rec Rec Rec Marked point
Legend: Liv - Liver, Rec - Rectum, Sto - Stomach

- Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IVa), - NAT

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 58 Stomach Adenocarcinoma 1 IIIa T3N1M0 Malignant
A2 2 M 65 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
A3 3 M 60 Stomach Adenocarcinoma 1 II T3N0M0 Malignant
A4 4 M 45 Stomach Adenocarcinoma (sparse) IIIa T3N1M0 Malignant
A5 5 M 75 Stomach Adenocarcinoma 2 IIIa T3N1M0 Malignant
A6 6 M 56 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
A7 7 M 53 Stomach Adenocarcinoma 2–3 II T3N0M0 Malignant
A8 8 M 53 Stomach Adenocarcinoma 3 II T3N0M0 Malignant
B1 9 M 62 Stomach Adenocarcinoma 2 II T3N0M0 Malignant
B2 10 F 73 Stomach Adenocarcinoma (sparse) II T2N1M0 Malignant
B3 11 M 53 Stomach Mucinous adenocarcinoma 3 IIIb T4N1M0 Malignant
B4 12 F 55 Stomach Adenocarcinoma 4 IIIb T3N3M0 Malignant
B5 13 M 62 Stomach Cancer adjacent normal stomach tissue NAT
B6 14 F 71 Stomach Cancer adjacent normal stomach tissue NAT
B7 15 F 55 Stomach Cancer adjacent normal gastric mucosa tissue NAT
B8 16 F 54 Stomach Cancer adjacent normal stomach tissue NAT
C1 17 M 58 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
C2 18 M 38 Liver Hepatocellular carcinoma 1 III T3N0M0 Malignant
C3 19 M 71 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
C4 20 M 63 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
C5 21 M 39 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
C6 22 F 52 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
C7 23 F 43 Liver Hepatocellular carcinoma 2 IVa T4N0M0 Malignant
C8 24 M 47 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
D1 25 M 63 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
D2 26 M 65 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
D3 27 F 69 Liver Hepatocellular carcinoma 2 IVa T4N1M0 Malignant
D4 28 M 50 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
D5 29 M 60 Liver Cancer adjacent normal liver tissue NAT
D6 30 M 63 Liver Cancer adjacent normal liver tissue with fatty degeneration NAT
D7 31 M 27 Liver Cancer adjacent normal liver tissue NAT
D8 32 F 66 Liver Cancer adjacent normal liver tissue NAT
E1 33 M 48 Rectum Adenocarcinoma 1 II T4N0M0 Malignant
E2 34 M 65 Rectum Adenocarcinoma 1 II T3N1M0 Malignant
E3 35 F 37 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
E4 36 F 68 Rectum Adenocarcinoma 2 II T3N0M0 Malignant
E5 37 M 55 Rectum Adenocarcinoma 2 II T3N0M0 Malignant
E6 38 M 57 Rectum Adenocarcinoma 2 II T4N0M0 Malignant
E7 39 F 72 Rectum Adenocarcinoma 2 I T2N0M0 Malignant
E8 40 M 26 Rectum Adenocarcinoma 3 II T4N0M0 Malignant
F1 41 F 62 Rectum Adenocarcinoma 3 II T3N0M0 Malignant
F2 42 F 57 Rectum Adenocarcinoma 3 II T4N0M0 Malignant
F3 43 F 38 Rectum Adenocarcinoma 3–4 III T3N2M0 Malignant
F4 44 M 51 Rectum Adenocarcinoma 3–4 III T3N1M0 Malignant
F5 45 F 58 Rectum Cancer adjacent normal rectum tissue NAT
F6 46 F 55 Rectum Cancer adjacent normal rectum tissue NAT
F7 47 F 25 Rectum Cancer adjacent normal rectum tissue (smooth muscle) NAT
F8 48 M 65 Rectum Cancer adjacent normal rectum tissue NAT
M 42 Adrenal gland Pheochromocytoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: